|
| |
The Face Of An Infant's Suffering; Can It Be Sugarcoated?
Sep 02, 2010 -- When your newborn infant is crying with uncomfortable teething or otherwise obviously suffering, feeding sugar to the little one has been a home remedy for years based on not only perceived behavior, but also physiological reactions. However, a new article by Dr...
|
QRxPharma Announces Interim Analysis Of Final Pivotal Phase 3 Study For MoxDuo®IR
Sep 02, 2010 -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced a successful interim analysis of its final MoxDuo IR pivotal Phase 3 study required for New Drug Application (NDA) submission. The analysis indicated the planned sample size of 140 patients has greater than 90% power to detect differences of analgesic effect, indicating there is no need to enrol additional patients...
|
Floridians Prepare To Take Back The State
Sep 02, 2010 -- September's National Pain Awareness Month has never been more important for the state of Florida. Recent data from the Florida Medical Examiner shows residents are dying at a rate of at least 7 per day as a result of prescription drug abuse...
|
Surgery To Repair Torn Shoulder Muscles In The Elderly Can Reduce Pain And Improve Function
Sep 02, 2010 -- Repairing torn shoulder muscles in elderly patients is often discouraged because of fears of complications. But a new study conducted at Rush University Medical Center has shown that minimally invasive, or arthroscopic, surgery can significantly improve pain and function...
|
BEMA Buprenorphine Phase 2 Study Results Selected For Presentation At Pain Week 2010
Sep 01, 2010 -- BioDelivery Sciences International, Inc. (Nasdaq:BDSI) announced today that its abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain...
|
After Needle Accidents, Hospitals Face Legal Dilemma If They Test Incapacitated Patients
Sep 01, 2010 -- Anaesthetists are calling for greater clarity on the legal implications of testing incapacitated patients for blood-borne viruses, after a survey found that this is often done following staff needlestick injuries, in possible breach of UK legislation...
|
QRxPharma To Sponsor Symposium At 13th World Congress On Pain Meeting
Sep 01, 2010 -- QRxPharma (ASX: QRX and OTCQX: QRXPY) announced it will sponsor a symposium at the 13th World Congress of Pain on 31 August, 2010 at Palais des congres de Montreal. The symposium, titled "Dual Opioid Therapy: Changing the Paradigm" will focus on preclinical and clinical data for MoxDuo®IR, an immediate-release Dual Opioid product for moderate to severe acute pain...
|
Glenmark Announces The Discovery Of A Novel Chemical Entity 'GRC 17536', A TRPA1 Receptor Antagonist, A Potential First-in-Class Molecule Globally
Sep 01, 2010 -- Glenmark Pharmaceuticals announced the discovery of a Novel Chemical Entity(NCE) 'GRC 17536'. The new NCE program is targeting TRPA1 receptor antagonists for pain and respiratory disorders...
|
MonoSol Rx Announces Reckitt Benckiser FDA Approval Of Suboxone® Sublingual Film For Treatment Of Opioid Dependence
Sep 01, 2010 -- MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in film pharmaceutical products, today announced that its partner, Reckitt Benckiser Pharmaceuticals Inc., a wholly-owned subsidiary of Reckitt Benckiser Group plc (LSE: RB), has received approval from the U.S...
|
"Pill Mill" Bill Requires State Certification By Sept. 1
Sep 01, 2010 -- Texans seeking pain relief soon can take comfort from a new state law requiring pain management clinics to be certified by the Texas Medical Board (TMB) by Sept. 1. Texas physicians hope the new law will put "pill mills," storefronts disguised as pain medicine clinics, out of commission...
|
|